Jim Simons Zynerba Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.33 - $1.39 $27,724 - $116,778	-84,013 Reduced 12.18%	605,700 $772,000
Q2 2023 Aug 11, 2023	BUY	$0.3 - $0.43 $36,003 - $51,605	120,013 Added 21.07%	689,713 $225,000
Q1 2023 May 12, 2023	SELL	$0.4 - $0.67 $108,320 - $181,436	-270,800 Reduced 32.22%	569,700 $245,000
Q4 2022 Feb 13, 2023	SELL	$0.5 - $0.72 $134,767 - $194,065	-269,535 Reduced 24.28%	840,500 $445,000
Q3 2022 Nov 14, 2022	BUY	$0.87 - $1.36 $324,888 - $507,871	373,435 Added 50.7%	1,110,035 $813,000
Q2 2022 Aug 12, 2022	BUY	$0.86 - $2.06 $351,052 - $840,892	408,200 Added 124.3%	736,600 $840,000
Q1 2022 May 13, 2022	SELL	$1.83 - $3.02 $109,772 - $181,154	-59,985 Reduced 15.44%	328,400 $673,000
Q4 2021 Feb 11, 2022	BUY	$2.88 - $4.3 $90,440 - $135,032	31,403 Added 8.8%	388,385 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$3.72 - $5.35 $1.33 Million - $1.91 Million	356,982 New	356,982 $1.51 Million
Q1 2021 May 13, 2021	SELL	$3.33 - $8.76 $479,520 - $1.26 Million	-144,000 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$3.27 - $4.64 $410,058 - $581,856	125,400 Added 674.19%	144,000 $475,000
Q3 2020 Nov 13, 2020	BUY	$3.23 - $4.3 $60,078 - $79,980	18,600 New	18,600 $62,000
Q1 2019 May 14, 2019	SELL	$3.6 - $6.22 $663,480 - $1.15 Million	-184,300 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$2.89 - $7.91 $532,627 - $1.46 Million	184,300 New	184,300 $547,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.